<DOC>
	<DOCNO>NCT02095847</DOCNO>
	<brief_summary>The goal clinical research study learn imaging ( call hysteroscopy ) use help guide tumor removal hysterectomy .</brief_summary>
	<brief_title>High-Resolution Microendoscopy Guide Hysteroscopic Tumor Resection</brief_title>
	<detailed_description>Tissue Collection Imaging : If participant find eligible take part study , standard-of-care hysterectomy , tissue sample collect . This sample use research routine testing . Participant sign separate consent form hysterectomy . During hysterectomy , photographs tissue take . Participant 's private area cover ( much possible ) , picture face take . A hysteroscopy also perform participant 's surgery . Participant 's doctor discus risk hysteroscopy participant ask sign separate consent form . A hysteroscopy allow doctor look inside uterus see tissue go collect research image . This procedure do tool call hysteroscope , long thin tube camera light . The hysteroscope insert though vagina uterus . An image display computer screen attach hysteroscope . The study doctor use image screen look different area uterus find location size tumor ( ) . This image may record future reference . After hysteroscopy , study doctor inject contrast dye ( Proflavine Hemisulfate ) participant 's uterus help doctor see lesion . A camera use photograph image uterus . The tissue collection image add 45 minute participant 's hysterectomy procedure . Length Study : Patient 's active participation study surgery . Follow-Up Call : About 30 day ( +/-7 day ) surgery , participant call ask . This investigational study . The hysteroscope commercially available FDA approve laparoscopic procedure . The use hysteroscope study research purpose . Proflavine Hemisulfate ( contrast dye ) commercially available FDA approve treat umbilical cord stump . Its use study consider investigational . Up 20 participant enrol study . All take part MD Anderson .</detailed_description>
	<mesh_term>Uterine Neoplasms</mesh_term>
	<mesh_term>Proflavine</mesh_term>
	<criteria>1 . Any patient confirm preoperative diagnosis endometrial cancer 2 . Histologic subtype limit endometrioid adenocarcinoma 3 . Patients grade endometrial cancer ( histologically confirm ) 4 . Patients contraindication surgery 5 . Patients scheduled hysterectomy laparotomy , laparoscopy , robotic surgery 6 . Patient must preoperative MRI within 30 day surgery MD Anderson Cancer Center . Outside image allow provided staff radiologist MD Anderson consider quality study optimal make definitive diagnosis regard myometrial invasion 7 . Patients must &lt; 50 % myometrial invasion preoperative MRI 8 . Patients must disease confine either anterior posterior wall uterus 9 . Ability understand willingness sign write Informed Consent Document ( ICD ) . 1 . Patients invasive uterine disease ( &gt; 50 % invasion ) preoperative MRI 2 . Patients diagnosis leiomyomata affect endometrium 3 . Patients prior history endometrial ablation 4 . Patients multifocal disease within uterus preoperative MRI 5 . Patients polypoid tumor protrude endocervical canal 6 . Patients histology endometrioid adenocarcinoma 7 . Patients undergone prior D &amp; C diagnosis endometrial cancer 8 . Patients exposure metformin within 6 month endometrial cancer diagnosis time diagnosis 9 . Patients &lt; 18 year age 10 . Patients know allergy proflavine acriflavine 11 . Patients pregnant nursing</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Uterine Cancer</keyword>
	<keyword>Endometrial cancer</keyword>
	<keyword>Hysterectomy</keyword>
	<keyword>Hysteroscopy</keyword>
	<keyword>High-resolution microendoscopy</keyword>
	<keyword>HRME</keyword>
	<keyword>Hysteroscopic-guided resection</keyword>
	<keyword>Proflavine</keyword>
</DOC>